In February 2017 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete after his sample tested positive for the prohibited substances Dexamphetamine (d-amphetamine, dextroamphetamine) and Levoamphetamine (l-amphetamine).
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and het was heard for the Doping Tribunal of the Sport Dispute Resolution Centre of Canada (SDRCC).
The Athlete admitted the violation and stated that he had used a ‘study pill’ provided by a friend and only after the notification he heard from his friend that the ‘study pill’ was a capsule of Adderall containing the prohibited substances. The Athlete requested for a reduced sanction as the violation was non intentional.
The CCES argued that the Athlete failed to prove, on the balance of probabilities, how the substances entered his system. The CCES explained that the Athlete initially reported that it was through consuming C4 pre-workout powder that the substance entered his body but he then changed his story explaining that he took his friend’s Adderall pill. According to the CCES, the Athlete has not provided sufficient evidence to prove any of these two explanations.
The Athlete filed a sequence of declarations, first by not indicating anything on his doping control form at collection time, then by stating that he consumed C4, and then by submitting that he had instead consumed a ‘study pill’. The Athlete’s first declaration was a fabricated lie, which misdirected the doping authorities’ resources in their legal and clinical analysis and research. It leaves the Sole Arbitrator with no reason to trust the Athlete’s last version.
Therefore the SDRCC Anti-Doping Tribunal concludes that he bears Significant Fault or Negligence and decides on 27 April 2017 to impose a 2 year period of ineligibility on the Athlete.
